AzurRx BioPharma Announces Presentation on Its Positive Phase II Data in MS1819-SD in Chronic Pancreatitis at the 2019 Digestive Disease Week Conference

NEXT STORY
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
PREV STORY
Helix BioPharma Corp. Announces Fiscal Second Quarter 2019 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Avian Influenza (Infectious Disease) Drugs Development Market Report 2021: Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type

author_avatar
NASDAQ Market News

IMV Inc. Reaches Multiple Milestones in Advanced Ovarian Cancer Clinical Trial

HALIFAX, Nova Scotia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Enrollment Completed for Phase 1b ...

author_avatar
NASDAQ Market News

Arch Oncology Strengthens Medical and Clinical Leadership Teams with Key Appointments

author_avatar
NASDAQ Market News